{
  "resourceType": "PlanDefinition",
  "id": "pd1",
  "meta": {
    "profile": [
      "http://hl7.org.nz/fhir/StructureDefinition/CcaPlanDefinition"
    ]
  },
  "extension": [
    {
      "extension": [
        {
          "url": "factor",
          "valueCodeableConcept": {
            "coding": [
              {
                "code": "TOUPDATE-SUPPORT4",
                "system": "http://snomed.info/sct",
                "display": "Diarrhoea risk"
              }
            ]
          }
        },
        {
          "url": "value",
          "valueCodeableConcept": {
            "text": "low"
          }
        }
      ],
      "url": "http://hl7.org.nz/fhir/StructureDefinition/support-factor"
    },
    {
      "extension": [
        {
          "url": "factor",
          "valueCodeableConcept": {
            "coding": [
              {
                "code": "TOUPDATE-SUPPORT8",
                "system": "http://snomed.info/sct",
                "display": "AntiFungal Prophylaxis"
              }
            ]
          }
        },
        {
          "url": "value",
          "valueCodeableConcept": {
            "text": "low"
          }
        }
      ],
      "url": "http://hl7.org.nz/fhir/StructureDefinition/support-factor"
    },
    {
      "extension": [
        {
          "url": "factor",
          "valueCodeableConcept": {
            "coding": [
              {
                "code": "TOUPDATE-SUPPORT2",
                "system": "http://snomed.info/sct",
                "display": "Hypersensitivity / Infusion related reaction ris"
              }
            ]
          }
        },
        {
          "url": "value",
          "valueCodeableConcept": {
            "text": "low"
          }
        }
      ],
      "url": "http://hl7.org.nz/fhir/StructureDefinition/support-factor"
    }
  ],
  "status": "draft",
  "version": "3.0.3",
  "title": "Colorectal Adjuvant FOLFOX (a7)",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code": "order-set"
      }
    ]
  },
  "publisher": "New Zealand Medicines Formulary LP",
  "date": "2020-06-29T20:14:18.417+12:00",
  "contained": [
    {
      "resourceType": "ActivityDefinition",
      "id": "d651591f-5f92-43c2-b13b-bfaf24681b86",
      "meta": {
        "profile": [
          "http://hl7.org.nz/fhir/StructureDefinition/CcaActivityDefinition"
        ]
      },
      "text": {
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Tragacanth administration, 3mg over 3 hours by continuous IV infusion</div>",
        "status": "additional"
      },
      "productCodeableConcept": {
        "coding": [
          {
            "code": "10711851000116105",
            "system": "https://nzulm.org.nz/nzmt",
            "display": "Tragacanth"
          }
        ]
      },
      "dosage": [
        {
          "text": "3 mg over 3 hours by IV infusion",
          "route": {
            "coding": [
              {
                "code": "180177004",
                "system": "http://snomed.info/sct",
                "display": "continuous intravenous infusion"
              }
            ]
          },
          "doseAndRate": [
            {
              "doseQuantity": {
                "value": 3,
                "system": "http://unitsofmeasure.org",
                "code": "mg"
              },
              "rateQuantity": {
                "value": 3,
                "system": "http://unitsofmeasure.org",
                "code": "h"
              }
            }
          ]
        }
      ],
      "status": "draft"
    }
  ],
  "useContext": [
    {
      "code": {
        "code": "focus",
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "code": "781382000",
            "system": "http://snomed.info/sct",
            "display": "Colorectal cancer"
          }
        ]
      }
    },
    {
      "code": {
        "code": "program",
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "code": "FOLFOX",
            "system": "http://snomed.info/sct",
            "display": "FOLFOX"
          }
        ]
      }
    }
  ],
  "relatedArtifact": [
    {
      "type": "citation",
      "display": "test",
      "url": "http://www.ncbi.nlm.nih.gov/pubmed/23434"
    },
    {
      "type": "citation",
      "display": "test2",
      "url": "http://www.ncbi.nlm.nih.gov/pubmed/34324"
    }
  ],
  "action": [
    {
      "description": "Administration of Cabergoline and Tragacanth daily over 14 days",
      "action": [
        {
          "definitionCanonical": "#5cd0c665-040c-4d7f-9106-8ecd56eab694",
          "description": "2mg of Cabergoline daily for 14 days by IV Infusion"
        },
        {
          "definitionCanonical": "#d651591f-5f92-43c2-b13b-bfaf24681b86",
          "description": "3mg of Tragacanth daily for 14 days by IV Infusion"
        }
      ]
    }
  ]
}
